Delta Asia International Corporation (TPEX:6762)
Taiwan · Delayed Price · Currency is TWD 172.00
-1.00 (-0.58%)
Jan 21, 2026, 2:31 PM CST
Delta Asia International Market Cap
Delta Asia International has a market cap or net worth of 6.05 billion as of January 21, 2026. Its market cap has decreased by -31.83% in one year.
Market Cap
6.05B
Enterprise Value
7.29B
Revenue
711.19M
Ranking
n/a
PE Ratio
102.02
Stock Price
172.00
Market Cap Chart
Since December 18, 2019, Delta Asia International's market cap has increased from 2.96B to 6.05B, an increase of 104.38%. That is a compound annual growth rate of 12.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 6.05B | -7.03% |
| Dec 31, 2025 | 6.51B | -21.84% |
| Dec 27, 2024 | 8.32B | 19.54% |
| Dec 29, 2023 | 6.96B | 16.96% |
| Dec 30, 2022 | 5.95B | 4.15% |
| Dec 30, 2021 | 5.72B | 14.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 254.20B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.97B |
| Lumosa Therapeutics | 31.25B |
| Center Laboratories | 31.09B |